# "Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"

> **NCT06289205** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Health Sciences Lahore** · enrollment: 120 (estimated)

## Conditions studied

- Proliferative Vitreoretinopathy

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT06289205
- **Lead sponsor:** University of Health Sciences Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03
- **Primary completion:** 2025-02
- **Final completion:** 2025-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289205, ""Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06289205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*